Get started
Author

Luc Janssens

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
2017 · Justin E. Davies, Sayan Sen, et al. · New England Journal of Medicine · 1,024
PDF
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
2018 · Pascal Vranckx, Marco Valgimigli, et al. · The Lancet · 838
PDF
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
2019 · Deepak L Bhatt, Philippe Gabriel Steg, et al. · The Lancet · 212
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
2022 · Sunil V. Rao, Bodo Kirsch, et al. · Circulation · 182
PDF
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
2019 · Anna Franzone, Eugène McFadden, et al. · Journal of the American College of Cardiology · 157
Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease
2018 · Yuetsu Kikuta, Christopher M. Cook, et al. · JACC: Cardiovascular Interventions · 129
PDF
Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute mycardial infarction receiving thrombolytic therapy
1993 · Frans Van De Werf, Luc Janssens, et al. · Journal of the American College of Cardiology · 112
PDF
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study
2024 · Kausik K Ray, Carlos Aguiar, et al. · European Journal of Preventive Cardiology · 95
PDF
The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis)
2017 · Stefan Verheye, Mathias Vrolix, et al. · JACC: Cardiovascular Interventions · 79
PDF
Real-time use of instantaneous wave–free ratio: Results of the ADVISE in-practice: An international, multicenter evaluation of instantaneous wave–free ratio in clinical practice
2014 · Ricardo Petraco, Rasha Al-Lamee, et al. · American Heart Journal · 76
PDF
1-Year Survival in a Randomized Trial of Facilitated Reperfusion
2009 · Stephen G. Ellis, Michal Tendera, et al. · JACC: Cardiovascular Interventions · 73
PDF
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial
2018 · Alexandra Lansky, William Wijns, et al. · The Lancet · 67
PDF
Durable Physiological Changes and Decreased Syncope Burden 12 Months After Unifocal Right-Sided Ablation Under Computed Tomographic Guidance in Patients With Neurally Mediated Syncope or Functional Sinus Node Dysfunction
2021 · Philippe Debruyne, Tom Rossenbacker, et al. · Circulation Arrhythmia and Electrophysiology · 63
PDF
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
2020 · Felice Gragnano, Dik Heg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 63
PDF
Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial
2021 · Pascal Vranckx, Marco Valgimigli, et al. · Journal of the American Heart Association · 55
PDF
Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment
2019 · Sayan Sen, Yousif Ahmad, et al. · Journal of the American College of Cardiology · 43
PDF
Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention
2010 · Gilles Montalescot, Stephen G. Ellis, et al. · JACC: Cardiovascular Interventions · 43
PDF
Coronary Revascularization Guided With Fractional Flow Reserve or Instantaneous Wave-Free Ratio: A 5-Year Follow-Up of the DEFINE FLAIR Randomized Clinical Trial
2024 · Javier Escaned, Alejandro Travieso, et al. · JAMA Cardiology · 41
PDF
Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy
2019 · Chee Hae Kim, Bon-Kwon Koo, et al. · JACC: Cardiovascular Interventions · 38
PDF
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
2018 · Taku Asano, Yuki Katagiri, et al. · EuroIntervention · 30
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study
2022 · Philippe van de Borne, André Peeters, et al. · Acta cardiologica. Supplementum · 24
PDF
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy
2017 · Dean Kereiakes, Ian Meredith, et al. · EuroIntervention · 24
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
2019 · Sergio Leonardi, Anna Franzone, et al. · BMJ Open · 23
PDF
Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: Results of the MEDCOR trial
2015 · Emanuele Barbato, Arnold Herman, et al. · Atherosclerosis · 23
2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent
2019 · Bo Xu, Yuichi Saito, et al. · JACC: Cardiovascular Interventions · 22
Works count: 68
Citation count: 4,586
H-index: 23
I10-index: 35
Year
Topic
Type